These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7700008)

  • 21. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
    Eur J Pharmacol; 1995 Apr; 277(2-3):223-8. PubMed ID: 7493612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
    Campbell DJ; Kladis A; Valentijn AJ
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    Golomb E; Abassi ZA; Cuda G; Stylianou M; Panchal VR; Trachewsky D; Keiser HR
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1496-506. PubMed ID: 7524366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous angiotensin II induces Fos-immunoreactivity in circumventricular organs of the lamina terminalis.
    McKinley MJ; Badoer E; Oldfield BJ
    Brain Res; 1992 Oct; 594(2):295-300. PubMed ID: 1450955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats.
    von Lutterotti N; Camargo MJ; Campbell WG; Mueller FB; Timmermans PB; Sealey JE; Laragh JH
    J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
    Kabour A; Henegar JR; Devineni VR; Janicki JS
    Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fos production in retrogradely labelled neurons of the lamina terminalis following intravenous infusion of either hypertonic saline or angiotensin II.
    Oldfield BJ; Badoer E; Hards DK; McKinley MJ
    Neuroscience; 1994 May; 60(1):255-62. PubMed ID: 8052417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.
    Gottlieb SS; Dickstein K; Fleck E; Kostis J; Levine TB; LeJemtel T; DeKock M
    Circulation; 1993 Oct; 88(4 Pt 1):1602-9. PubMed ID: 8403307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain angiotensin AT-2 receptor antagonism and water intake.
    Rowland NE; Fregly MJ
    Brain Res Bull; 1993; 32(4):391-4. PubMed ID: 8221129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19.
    Dourish CT; Duggan JA; Banks RJ
    Eur J Pharmacol; 1992 Jan; 211(1):113-6. PubMed ID: 1618259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The advantages of angiotensin II antagonism.
    Burnier M; Waeber B; Brunner HR
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
    Morton JJ; Beattie EC; MacPherson F
    J Vasc Res; 1992; 29(3):264-9. PubMed ID: 1387008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of c-fos in forebrain circumventricular organs after renal artery stenosis.
    Ciriello J; Rosas-Arellano MP; Solano-Flores LP
    Brain Res; 2004 Jan; 995(1):109-17. PubMed ID: 14644476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
    Lark LA; Wappel SM; Weyhenmeyer JA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II responsiveness of rat paraventricular and subfornical organ neurons in vitro.
    Li Z; Ferguson AV
    Neuroscience; 1993 Jul; 55(1):197-207. PubMed ID: 8394518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of vascular angiotensin release.
    Kato H; Iwai N; Inui H; Kimoto K; Uchiyama Y; Inagami T
    Hypertension; 1993 Apr; 21(4):446-54. PubMed ID: 8458646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
    Schnecko A; Witte K; Lemmer B
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.